Skip to content

The effectiveness of new method of making custom made pressure garment in breast cancer related lymphedema -A randomized control trial

The effectiveness of new method of making custom made pressure garment in breast cancer related lymphedema -A randomized control trial

Status
Unknown
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20221212005
Enrollment
64
Registered
2022-12-12
Start date
2022-12-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cellulis in breast cancer related lymphedema Breast cancer related lymphedema,pressure garment

Interventions

intervention group will be educated about complex decongestive therapy which consist of manaul lymphatic drainage, skincare, exercise and custom made pressure garment by new method of making ,control
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
new method of making custom made pressure garment in breast cancer related lymphedema,control

Sponsors

Faculty of medicine Siriraj hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age more than 18 years old 2. stage1 or stage2 upper extremity lymphedema secondary to breast cancer defined by international society of lymphology

Exclusion criteria

Exclusion criteria: 1. Lymphagitis 2. Recurrent of breast cancer 3. Ongoing treatment of braest cancer (surgery,chemotherapy,radiation) 4. Ongoing treatment of lymphdema by other method 5. Pitting edema both legs from medical condition

Design outcomes

Primary

MeasureTime frame
Arm volume changed 3weeks millimeter

Secondary

MeasureTime frame
Qaulity of life 3weeks questionnaire

Countries

Thailand

Contacts

Public ContactKingkaew Pajareya

Faculty of medicine Siriraj hospital, Mahidol university

kingkaew.paj@gmail.com0832925200

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026